About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

New Therapy To Treat Advanced Form Of Parkinsonís Disease

by Pooja Shete on January 22, 2021 at 8:17 PM
New Therapy To Treat Advanced Form Of Parkinsonís Disease

A promising therapy has been discovered that targets the protein BMP5/7 and slows down or stops the progress of Parkinson's disease.

The study conducted at Ben-Gurion University of the Negev is published in the clinical neurology journal Brain.

Advertisement


Parkinson's disease affects over one million people in U.S. and 10 million worldwide. Parkinson's disease causes symptoms like tremors and severe movement impairment due to progressive degeneration of dopaminergic neurons.

The protein present in all human brains called 'alpha-synuclein' misfolds and forms toxic clumps in the cells found to be the main cause of the Parkinson's disease. Current therapies for Parkinson's improve symptoms but they are not effective in the advanced stage of illness and they do not slow or cure the disease.
Advertisement

The researchers discovered that BMP5/7 signaling in neurons was significantly reduced in dopamine-producing brain cells, which can contribute to Parkinson's disease progression.

Dr. Claude Brodski, M.D., head of the BGU's Laboratory for Molecular Neuroscience said, "Indeed, we found that BMP5/7 treatment can, in a Parkinson's disease mouse model, efficiently prevent movement impairments caused by the accumulation of alpha-synuclein and reverse the loss of dopamine-producing brain cells. These findings are very promising, since they suggest that BMP5/7 could slow or stop Parkinson's disease progression. Currently, we are focusing all our efforts on bringing our discovery closer to clinical application."

Dr. Galit Mazooz Perlmuter, senior vice president of business development, bio-pharma at BGN Technologies said that there is a need for new therapies for the treatment of Parkinson's disease specifically for the treatment of advanced stages of the disease.

Dr. Galit Mazooz Perlmuter said, "Dr. Brodski's findings, although still in their early stages, offer a disease-modified drug target that will address this devastating condition. We are now seeking an industry partner for further development of this patent pending invention."

Source: Medindia
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Research News

Brain Circuits That Shape Bedtime Rituals in Mice
New study sheds light on the intrinsic, yet often overlooked, role of sleep preparation as a hardwired survival strategy.
NELL-1 Protein Aids to Reduce Bone Loss in Astronauts
Microgravity-induced bone loss in space, can be reduced by systemic delivery of NELL-1, a protein required for bone growth and its maintenance.
Connecting Genetic Variants to the Alzheimer's Puzzle
Researchers establish connections between Alzheimer's-linked genetic alterations and the functioning of brain cells.
Gene Therapy Sparks Spinal Cord Regeneration
Team at NeuroRestore introduces a groundbreaking gene therapy that has effectively promoted nerve regrowth and reconnection, post spinal cord injury.
Unlocking the Gut Microbiome's Influence on Bone Density
Scientists aim to pinpoint particular functional pathways affected by these bacteria that may have an impact on skeletal health.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

New Therapy To Treat Advanced Form Of Parkinsonís Disease Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests